Clinical Trial Update: Assessment of Intralipid Efficacy in Women With Unexplained Recurrent Implantation Failure [Phase 4]

View source ↗

Summary

This update reports the completed results of a Phase 4 trial assessing whether intravenous Intralipid improves outcomes for women with unexplained recurrent imp…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Implantation Failure
• Infertility

Drugs mentioned

• Intralipid (intravenous lipid emulsion)

Snippet

Sponsor: Dar El Teb Institute | Conditions: Subfertility | Phase 4 | Status: COMPLETED